Abstract：Alagille syndrome (ALGS) is an autosomal dominant disease affecting multiple systems including the liver, heart, skeleton, eyes, kidneys and face. This paper reports the clinical and genetic features of an infant with this disease. A 3-month-and-10-day-old female infant was referred to the hospital with jaundiced skin and sclera for 3 months. Physical examination revealed wide forehead and micromandible. A systolic murmur of grade 3-4/6 was heard between the 2th and 3th intercostal spaces on the left side of the sternum. The abdomen was distended, and the liver palpable 3 cm under the right subcostal margin with a medium texture. Serum biochemistry analysis revealed abnormal liver function indices, with markedly elevated bilirubin (predominantly direct bilirubin), total bile acids (TBA) and gamma-glutamyl transpeptidase (GGT). Atrial septal defect and pulmonary stenosis were detected on echocardiography. Next generation sequencing detected entire deletion of the JAG1 gene, and then chromosomal microarray analysis revealed a novel interstitial deletion of 3.0 Mb in size on chr20p12.3p12.2, involving JAG1 gene. The child had special facial features, heart malformations, and cholestasis, and based on the genetic findings, ALGS was definitively diagnosed. Thereafter, symptomatic and supportive treatment was introduced. Thus far, the infant had been followed up till his age of 11 months. The hyperbilirubinemia got improved, but GGT and TBA were persistently elevated, and the long-term outcome needs to be observed. This study extended the JAG1 mutation spectrum, and provided laboratory evidences for the diagnosis and treatment of the patient, and for the genetic counseling and prenatal diagnosis in the family.
LI Hua,LIU Jia-Jia,DENG Mei et al. Clinical and genetic study of an infant with Alagille syndrome:identification of a novel chromosomal interstitial deletion including JAG1 gene[J]. CJCP, 2017, 19(10): 1098-1103.
McElhinney DB, Krantz ID, Bason L, et al. Analysis of cardiovascular phenotype and genotype-phenotype correlation in individuals with a JAG1 mutation and/or Alagille syndrome[J]. Circulation, 2002, 106(20):2567-2574.
[2]
Balistreri WF, Bezerra JA, Jansen P, et al. Intrahepatic cholestasis:summary of an American Association for the Study of Liver Diseases single-topic conference[J]. Hepatology, 2005, 42(1):222-235.
[3]
Alagille D, Odièvre M, Gautier M, et al. Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental, and sexual development, and cardiac murmur[J]. J Pediatr, 1975, 86(1):63-71.
[4]
Kamath BM, Yin W, Miller H, et al. Outcomes of liver transplantation for patients with Alagille syndrome:the studies of pediatric liver transplantation experience[J]. Liver Transpl, 2012, 18(8):940-948.
[5]
Leonard LD, Chao G, Baker A, et al. Clinical utility gene card for:Alagille syndrome (ALGS)[J]. Eur J Hum Genet, 2014, 22(3):e1-e4.
[6]
Vanorny DA, Prasasya RD, Chalpe AJ, et al. Notch signaling regulates ovarian follicle formation and coordinates follicular growth[J]. Mol Endocrinol, 2014, 28(4):499-511.
Li L, Dong J, Wang X, et al. JAG1 mutation spectrum and origin in Chinese children with clinical features of Alagille syndrome[J]. PLoS One, 2015, 10(6):e0130355.
[9]
Kamath BM, Thiel BD, Gai X, et al. SNP array mapping of chromosome 20p deletions:genotypes, phenotypes, and copy number variation[J]. Hum Mutat, 2009, 30(3):371-378.
[10]
Alagille D, Estrada A, Hadchouel M, et al. Syndromic paucity of interlobular bile ducts (Alagille syndrome or arteriohepatic dysplasia):review of 80 cases[J]. J Pediatr, 1987, 110(2):195-200.
[11]
Li L, Krantz ID, Deng Y, et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1[J]. Nat Genet, 1997, 16(3):243-251.
[12]
Kamath BM. Alagille syndrome[M]//Suchy FJ, Sokal RJ, Balistreri WF, et al. Liver disease in children. 3rd ed. New York:Cambridge University Press, 2007:326-345.
[13]
Guru Murthy GS, Rana BS, Das A, et al. Alagille syndrome:a rare disease in an adolescent[J]. Dig Dis Sci, 2012, 57(11):3035-3037.
[14]
Miller DT, Adam MP, Aradhya S, et al. Consensus statement:chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies[J]. Am J Hum Genet, 2010, 86(5):749-764.
[15]
Angus J. Genetics[M]//Lissauer T, Carrol W. Illustrated textbook of pediatrics. 5 th ed. Amsterdam:Elsevier, 2017:128.
[16]
Dhorne-Pollet S, Deleuze JF, Hadchouel M, et al. Segregation analysis of Alagille syndrome[J]. J Med Genet, 1994, 31(6):453-457.
[17]
Turnpenny PD, Ellard S. Alagille syndrome:pathogenesis, diagnosis and management[J]. Eur J Hum Genet, 2012, 20(3):251-257.
[18]
Whitington PF, Whitington GL. Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis[J]. Gastroenterology, 1988, 95(1):130-136.
[19]
Mozer-Glassberg Y, Hojsak I, Zevit N, et al. Pruritus responsive to naltrexone in a patient with cholestatic liver disease[J]. Isr Med Assoc J, 2011, 13(2):111-112.
[20]
Cunningham JW, McElhinney DB, Gauvreau K, et al. Outcomes after primary transcatheter therapy in infants and young children with severe bilateral peripheral pulmonary artery stenosis[J]. Circ Cardiovasc Interv, 2013, 6(4):460-467.
[21]
Mainwaring RD, Sheikh AY, Punn R, et al. Surgical outcomes for patients with pulmonary atresia/major aortopulmonary collaterals and Alagille syndrome[J]. Eur J Cardiothorac Surg, 2012, 42(2):235-240.
[22]
Fukumoto M, Ikeda T, Sugiyama T, et al. A case of Alagille syndrome complicated by intraocular lens subluxation and rhegmatogenous retinal detachment[J]. Clin Ophthalmol, 2013, 7:1463-1465.
[23]
Shrivastava R, Williams A, Mikhail A, et al. An unusual cause of hypertension and renal failure:a case series of a family with Alagille syndrome[J]. Nephrol Dial Transplant, 2010, 25(5):1501-1506.
